Results 191 to 200 of about 275,895 (351)

Induced Hypertension in Preventing Cerebral Infarction in Delayed Cerebral Ischemia After Subarachnoid Hemorrhage [PDF]

open access: bronze, 2018
N. Marlou Haegens   +5 more
openalex   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence for regulatory science and innovation in pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

HIV-associated multiple intracerebral hemorrhages [PDF]

open access: yes, 2005
Arbusow, Viktor   +3 more
core   +1 more source

Predictive value of cerebrovascular time constant for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage [PDF]

open access: hybrid
Agnieszka Uryga   +4 more
openalex   +1 more source

Possible Role for Vascular Cell Proliferation in Cerebral Vasospasm After Subarachnoid Hemorrhage [PDF]

open access: bronze, 2003
Cecil O. Borel   +8 more
openalex   +1 more source

A formula-fed infant with profound dehydration, cerebral venous sinus thrombosis, and intracranial hemorrhage

open access: hybrid, 2021
Elizabeth Yakaboski   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy